Rectal Cancer Stage III

Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial

Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer

Diagnostic Accuracy and Prognostic Value of 18F FDG PET-CT in the Follow up of Patients With Colorectal Carcinoma.

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial

Can Neoadjuvant Chemoradiotherapy be Ommited in Mid-rectal Cancer

Bovine Reinforcement in Stomach, Colorectal and Lung Operation

Short RT Versus RCT,Followed by Chemo.and Organ Preservation for Interm and High-risk Rectal Cancer Patients

ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer

The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer

Induction Chemotherapy Before or After Preoperative Chemoradiotherapy and Surgery for Locally Advanced Rectal Cancer

TNT to Increase the Clinical Complete Response Rate for Distal LARC

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Sentinel Lymph Node Biopsy in Rectal Cancer

Using Artificial Intelligence to Predict Rectal Cancer Outcomes

"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".

The Role of Serum Adipokines in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer

UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer